Art

J-GLOBAL ID：201402200542525291   Reference number：14A0270895

Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo

in vivo抗腫瘍活性の制御放出と増強のためのハイブリッドペプチドと生物分解性ゼラチンヒドロゲルとの組合わせ

Author (8)： GAOWA Arong (Dep. of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Univ., Kyoto, JPN) ,  HORIBE Tomohisa (Dep. of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Univ., Kyoto, JPN) ,  KOHNO Masayuki (Dep. of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Univ., Kyoto, JPN) ,  SATO Keisuke (Dep. of Biomaterials, Field of Tissue Engineering, Inst. for Frontier Medical Sciences, Kyoto Univ., Kyoto, JPN) ,  HARADA Hiroshi (Dep. of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto Univ., Kyoto, JPN) ,  HIRAOKA Masahiro (Dep. of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto Univ., Kyoto, JPN) ,  TABATA Yasuhiko (Dep. of Biomaterials, Field of Tissue Engineering, Inst. for Frontier Medical Sciences, Kyoto Univ., Kyoto, JPN) ,  KAWAKAMI Koji (Dep. of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Univ., Kyoto, JPN)
Material： Journal of Controlled Release  (J Control Release)
Volume： 176  Page： 1-7  Publication year： Feb. 28, 2014 
JST Material Number： C0308D  ISSN： 0168-3659  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *delayed action preparation ,...
Semi thesaurus term： *ハイブリッドペプチド ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0270895&from=J-GLOBAL&jstjournalNo=C0308D") }}

JST classification (1)： Basic biopharmacy  (GY01021U)

Reference (37)：

• M. Kohno, T. Horibe, M. Haramoto, Y. Yano, K. Ohara, O. Nakajima, K. Matsuzaki, K. Kawakami, A novel hybrid peptide targeting EGFR-expressing cancers, Eur. J. Cancer 47 (2011) 773-783.
• N. Tada, T. Horibe, M. Haramoto, K. Ohara, M. Kohno, K. Kawakami, A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity, Biochem. Biophys. Res. Commun. 407 (2011) 383-388.
• M. Kawamoto, T. Horibe, M. Kohno, K. Kawakami, A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells, BMC Cancer 11 (2011) 359-372.
• L Yang, T. Horibe, M. Kohno, M. Haramoto, K. Ohara, R.K. Puri, K. Kawakami, Targeting interleukin-4 receptor α with hybrid peptide for effective cancer therapy, Mol. Cancer Ther. 11 (2012) 235-243.
• T. Horibe, M. Kawamoto, M. Kohno, K. Kawakami, Cytotoxic activity to acute myeloid leukemia cells by Antp-TPR hybrid peptide targeting Hsp90, J. Biosci. Bioeng. 114 (2012) 96-103.

Terms in the title (7)： 抗腫瘍活性 ,  放出 ,  増強 ,  ペプチド ,  生物分解性 ,  ゼラチンヒドロゲル ,  組合わせ